NSABP B-37 IBCSG 27-02

Closed to Accrual & Treatment

Return to Protocol Table

Protocol Information

Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants

A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Loco-Regional Relapse of Breast Cancer

Principal Investigator

Irene Wapnir

Status

Closed to Accrual & Treatment

Date Opened To Accrual

January 14, 2005

Date Closed To Accrual

January 29, 2010

Date of Study Termination

August 13, 2018


Disease Site

Breast [BR] Breast

Phase

III

Developmental Therapeutics

No

Primary Objective

To evaluate the efficacy of adjuvant chemotherapy after radical local treatment of a first loco-regional recurrence of breast cancer

Patient Population

Patients with radically treated isolated local and/or regional recurrence of invasive breast cancer after mastectomy or breast-conserving surgery

Protocol Record Retention Dates
Date Records No Longer to be Kept by US Sites: 08/13/2033
Date Records No Longer to be kept by Canadian Sites: 08/13/2033

Target Accrual

265

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.